All News

Estrogen decline during menopause alters fat, muscle, and lipid metabolism; multimodal lifestyle strategies help reduce cardiovascular risk.

Early intervention during perimenopause can prevent long-term osteoporosis through timely screening and intermittent therapy strategies.

A systematic review found estrogen-based hormone therapy did not consistently reduce anxiety or depression in midlife women.

A new study finds that earlier menopause and reduced cardiac function may together worsen brain health, highlighting dementia risk factors.

Cynthia Stuenkel, MD, reviews diagnosis, management, and fertility considerations in women with primary ovarian insufficiency.

CBT adapted for menopause shows benefits for vasomotor symptoms, mood, and sleep, according to Danette Conklin, PhD, at The Menopause Society.

Elinzanetant shows a strong safety profile with no liver toxicity and minimal side effects in menopausal women with vasomotor symptoms.

Following positive safety and efficacy data, the FDA has approved elinzanetant to manage vasomotor symptoms in postmenopausal women.

Women with early natural menopause face a 27% higher risk of metabolic syndrome, underscoring the need for early cardiometabolic screening.

Levonorgestrel IUD offers localized progesterone delivery for endometrial protection during hormone therapy, with minimal systemic effects.

Melissa Mauskar, MD, discusses overlapping vulvar conditions, patient counseling, and the importance of multidisciplinary care

Real-world data show fezolinetant improves vasomotor symptoms, sleep, and work productivity in postmenopausal women.

At The Menopause Society Annual Meeting, Caroline Mitchell, MD, MPH, emphasized individualized, evidence-based care and the safety of topical hormones for GSM.

Starting estrogen therapy in perimenopause was associated with reduced risks of breast cancer, heart attack, and stroke, study shows.

A new study found that transdermal hormone therapy may lower anxiety and depression risk compared with oral therapy in postmenopausal women.

Menopause remains a taboo topic in many cultures, yet women seek to educate themselves and support each other through shared experiences.

A Wake Forest study finds that provider specialty and training shape how women receive medication treatment for menopause symptoms.

Andrew Kaunitz, MD, shares how older women can explore safe contraceptive options while understanding fertility risks.

Most perimenopausal and menopausal women report digestive symptoms, but few receive diagnosis or adequate care, new UK study finds.

Researchers highlight overlap between menopause and TBI symptoms, calling for hormone-informed tools in brain injury assessment.

Tebipenem HBr met primary endpoints in a phase 3 trial, showing oral efficacy comparable to IV carbapenem for complicated urinary tract infections.

A study reveals a sharp rise in telehealth medication abortion use following the Dobbs v Jackson Women’s Health Organization ruling.

A review presented at The Menopause Society 2025 highlights the links between menopause-related brain changes and cognitive function.

A large TriNetX analysis found hormone therapy use in postmenopausal women was linked to a higher incidence of autoimmune diseases.

In a study led by Eugene Declercq, PhD, MBA, infants born to mothers who died during or after pregnancy faced higher mortality rates.

A study found that prenatal exposure to antenatal corticosteroids increases the long-term risk of respiratory and nonrespiratory infections.

Moe Takenoshita, MBBCh, found that cesarean delivery was linked to a 16% higher risk of developing sleep disorders within a year after childbirth.

Complications from pelvic floor polypropylene mesh appear linked to host immune response rather than oxidative material degradation.